These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 495408)

  • 1. Ethmozin: a new antiarrhythmic agent developed in the USSR. Efficacy and tolerance.
    Morganroth J; Pearlman AS; Dunkman WB; Horowitz LN; Josephson ME; Michelson EL
    Am Heart J; 1979 Nov; 98(5):621-8. PubMed ID: 495408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.
    Podrid PJ; Lyakishev A; Lown B; Mazur N
    Circulation; 1980 Feb; 61(2):450-7. PubMed ID: 7351070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination ethacizin and ethmozin treatment of resistant ventricular ectopy: theoretical, experimental, and clinical study.
    Nesterenko VV; Anyukhovsky EP; Bugrij EM; Starmer CF; Beloshapko GG; Makielski JC; Kuzmin AV; Menshikov MJu ; Mazaev AV; Rosenshtraukh LV
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):501-8. PubMed ID: 7515997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of ethmozin on canine myocardium.
    Ruffy R; Rozenshtraukh LV; Elharrar V; Zipes DP
    Cardiovasc Res; 1979 Jun; 13(6):354-63. PubMed ID: 476756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of ethmozin in patients with ventricular tachycardia.
    Mann DE; Luck JC; Herre JM; Magro SA; Yepsen SC; Griffin JC; Pratt CM; Wyndham CR
    Am Heart J; 1984 Apr; 107(4):674-9. PubMed ID: 6367405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of intravenous infusion of ethmozin in patients with chronic ventricular arrhythmias].
    Merkulova IN; Piotrovskiĭ VK; Metelitsa VI; Romina IN; Blank ML
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):25-31. PubMed ID: 2472818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1983 Dec; 227(3):578-86. PubMed ID: 6317840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
    Chazov EI; Rosenshtraukh LV; Shugushev KK
    Am Heart J; 1984 Sep; 108(3 Pt 1):483-9. PubMed ID: 6382989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
    Arnsdorf MF; Sawicki GJ
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1158-66. PubMed ID: 2495352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy.
    Salerno DM; Sharkey PJ; Granrud GA; Asinger RW; Hodges M
    Clin Pharmacol Ther; 1987 Aug; 42(2):201-9. PubMed ID: 3301153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the anti-arrhythmia agent ethmozin on the refractory period of the accessory pathway in Wolff-Parkinson-White syndrome].
    Rakovec P; Kenda MF
    Wien Med Wochenschr; 1986 Feb; 136(3):65-6. PubMed ID: 3515775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethacizin: a new efficacious Soviet antiarrhythmic drug of the phenothiazine group.
    Rosenshtraukh LV; Shugushev KK; Smetnev AS
    Am Heart J; 1986 Nov; 112(5):932-9. PubMed ID: 3535466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin.
    Scamps F; Undrovinas A; Vassort G
    Am J Physiol; 1989 Mar; 256(3 Pt 1):C549-59. PubMed ID: 2538064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.
    Zipes DP; Troup PJ
    Am J Cardiol; 1978 May; 41(6):1005-24. PubMed ID: 352121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of stretching on the action potentials of the human and rabbit ventricular myocardium].
    Shkliar TF; Markhasin VS; Savichevskiĭ MS
    Biull Eksp Biol Med; 1987 Mar; 103(3):259-61. PubMed ID: 3548837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
    Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
    Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of efficacy during long-term cifenline therapy: development of antiarrhythmic resistance?
    Mohiuddin SM; Hee TT; Hunter CB; Hilleman DE; Sketch MH
    Ann Pharmacother; 1993 May; 27(5):550-4. PubMed ID: 8347900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.